+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Atherectomy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 245 Pages
  • June 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5913381
The global atherectomy devices market is poised for sustained growth, driven by the rising prevalence of cardiovascular and peripheral arterial diseases and the increasing demand for minimally invasive treatment options. With the introduction of advanced technologies and growing healthcare infrastructure, the market is expected to showcase significant progress over the coming years.

Market Insights

Between 2022 and 2032, the atherectomy devices market is anticipated to demonstrate robust growth. The market is projected to rise from a valuation of US$ 1.4 billion in 2025 to US$ 2.5 billion by 2032, expanding at a compound annual growth rate (CAGR) of 8.64%. This consistent growth reflects the increasing burden of atherosclerosis and related conditions worldwide, as well as a growing emphasis on advanced cardiovascular care.

Key Market Drivers

A multitude of factors is driving the global demand for atherectomy devices:

Rising Burden of Atherosclerosis, Diabetes, and Obesity

An upsurge in chronic conditions such as atherosclerosis, obesity, and diabetes is significantly contributing to the demand for atherectomy procedures. These underlying health issues are major contributors to peripheral artery disease (PAD) and coronary artery disease (CAD), which necessitate efficient and less invasive treatment approaches.

Growing Incidence of PAD and CAD

The global increase in PAD and CAD cases has created a fertile ground for the expansion of atherectomy devices. These devices provide a safer, more effective alternative to conventional surgical procedures, ensuring patient comfort, shorter recovery times, and fewer complications. Smoking, hypertension, and sedentary lifestyles are further fueling the demand.

Increasing Adoption of Laser Atherectomy Devices

Laser-based devices are gaining popularity due to their superior precision, enhanced procedural control, and minimal damage to surrounding tissues. Their ability to remove thrombi, debulk plaque, and eliminate procoagulant elements is positioning laser atherectomy systems as a favorable choice across medical facilities.

Technological Innovation

Rapid technological advances are revolutionizing the atherectomy device Analysis. Enhanced device functionality, improved materials, and minimally invasive delivery systems are boosting physician confidence and increasing their adoption in hospital and outpatient settings. Continued investment in R&D by manufacturers is expected to further stimulate market growth.

Business Opportunity

Emerging markets present significant untapped potential for the atherectomy devices sector. As healthcare access expands and awareness of vascular diseases grows in countries across Asia, Latin America, and the Middle East, manufacturers have a unique opportunity to penetrate these regions with cost-effective, advanced solutions. Additionally, strategic partnerships, acquisitions, and regional expansions by leading players are further shaping market competitiveness.

Regional Analysis

North America is currently the frontrunner in the global atherectomy devices market, owing to its advanced healthcare infrastructure, a high prevalence of cardiovascular diseases, and the presence of leading market players. Europe follows closely, with countries like Germany, France, and the UK leading the regional growth due to increased adoption of minimally invasive procedures and favorable reimbursement scenarios.

Asia Pacific is emerging as a promising market, propelled by improving healthcare systems, rising awareness, and a rapidly growing elderly population. India and China are expected to offer lucrative growth avenues due to their large patient pools and increasing healthcare investments.

Key Players

The global atherectomy devices market is moderately consolidated, with prominent players focusing on both organic and inorganic strategies to strengthen their portfolios. Strategic product launches and regulatory approvals are driving competition.
  • Medtronic Plc.
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Avinger, Inc.
  • Koninklijke Philips N.V. (including Spectranetics and Volcano)
Notably, Royal Philips launched the Nexcimer laser system in North America, aimed at treating both peripheral and coronary artery conditions. Similarly, Cardiovascular Systems, Inc. achieved CE Mark approval for its Diamondback 360 Coronary Orbital Atherectomy System, enhancing its presence in the European market.

Impact of COVID-19

The outbreak of COVID-19 led to a temporary decline in the demand for atherectomy devices due to deferred elective procedures and hospital resource reallocation. However, the market rebounded post-2021, fueled by the resumption of routine surgical interventions and increased focus on cardiovascular health following the pandemic.

Market Segmentation

By Indication:

  • Peripheral Artery Diseases
  • Coronary Artery Diseases

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Atherectomy Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Atherectomy Devices Market Outlook, 2019-2032
3.1. Global Atherectomy Devices Market Outlook, by Type, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Directional Atherectomy
3.1.1.2. Rotational Atherectomy
3.1.1.3. Orbital Atherectomy
3.1.1.4. Laser Atherectomy
3.2. Global Atherectomy Devices Market Outlook, by Indication, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Coronary Artery Diseases
3.2.1.2. Peripheral Artery Diseases
3.3. Global Atherectomy Devices Market Outlook, by End User, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Hospital
3.3.1.2. Ambulatory surgical Centers
3.3.1.3. Others
3.4. Global Atherectomy Devices Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Atherectomy Devices Market Outlook, 2019-2032
4.1. North America Atherectomy Devices Market Outlook, by Type, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Directional Atherectomy
4.1.1.2. Rotational Atherectomy
4.1.1.3. Orbital Atherectomy
4.1.1.4. Laser Atherectomy
4.2. North America Atherectomy Devices Market Outlook, by Indication, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Coronary Artery Diseases
4.2.1.2. Peripheral Artery Diseases
4.3. North America Atherectomy Devices Market Outlook, by End User, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Hospital
4.3.1.2. Ambulatory surgical Centers
4.3.1.3. Others
4.4. North America Atherectomy Devices Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. U.S. Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
4.4.1.2. U.S. Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
4.4.1.3. U.S. Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
4.4.1.4. Canada Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
4.4.1.5. Canada Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
4.4.1.6. Canada Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Atherectomy Devices Market Outlook, 2019-2032
5.1. Europe Atherectomy Devices Market Outlook, by Type, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Directional Atherectomy
5.1.1.2. Rotational Atherectomy
5.1.1.3. Orbital Atherectomy
5.1.1.4. Laser Atherectomy
5.2. Europe Atherectomy Devices Market Outlook, by Indication, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Coronary Artery Diseases
5.2.1.2. Peripheral Artery Diseases
5.3. Europe Atherectomy Devices Market Outlook, by End User, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Hospital
5.3.1.2. Ambulatory surgical Centers
5.3.1.3. Others
5.4. Europe Atherectomy Devices Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Germany Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.4.1.2. Germany Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
5.4.1.3. Germany Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
5.4.1.4. U.K. Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.4.1.5. U.K. Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
5.4.1.6. U.K. Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
5.4.1.7. France Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.4.1.8. France Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
5.4.1.9. France Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
5.4.1.10. Italy Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.4.1.11. Italy Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
5.4.1.12. Italy Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
5.4.1.13. Turkey Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.4.1.14. Turkey Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
5.4.1.15. Turkey Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
5.4.1.16. Russia Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.4.1.17. Russia Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
5.4.1.18. Russia Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
5.4.1.19. Rest of Europe Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
5.4.1.20. Rest of Europe Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
5.4.1.21. Rest of Europe Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Atherectomy Devices Market Outlook, 2019-2032
6.1. Asia Pacific Atherectomy Devices Market Outlook, by Type, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Directional Atherectomy
6.1.1.2. Rotational Atherectomy
6.1.1.3. Orbital Atherectomy
6.1.1.4. Laser Atherectomy
6.2. Asia Pacific Atherectomy Devices Market Outlook, by Indication, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Coronary Artery Diseases
6.2.1.2. Peripheral Artery Diseases
6.3. Asia Pacific Atherectomy Devices Market Outlook, by End User, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Hospital
6.3.1.2. Ambulatory surgical Centers
6.3.1.3. Others
6.4. Asia Pacific Atherectomy Devices Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. China Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
6.4.1.2. China Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
6.4.1.3. China Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
6.4.1.4. Japan Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
6.4.1.5. Japan Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
6.4.1.6. Japan Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
6.4.1.7. South Korea Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
6.4.1.8. South Korea Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
6.4.1.9. South Korea Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
6.4.1.10. India Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
6.4.1.11. India Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
6.4.1.12. India Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
6.4.1.13. Southeast Asia Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
6.4.1.14. Southeast Asia Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
6.4.1.15. Southeast Asia Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
6.4.1.16. Rest of Asia Pacific Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
6.4.1.17. Rest of Asia Pacific Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
6.4.1.18. Rest of Asia Pacific Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Atherectomy Devices Market Outlook, 2019-2032
7.1. Latin America Atherectomy Devices Market Outlook, by Type, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Directional Atherectomy
7.1.1.2. Rotational Atherectomy
7.1.1.3. Orbital Atherectomy
7.1.1.4. Laser Atherectomy
7.2. Latin America Atherectomy Devices Market Outlook, by Indication, Value (US$ Bn), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Coronary Artery Diseases
7.2.1.2. Peripheral Artery Diseases
7.3. Latin America Atherectomy Devices Market Outlook, by End User, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Hospital
7.3.1.2. Ambulatory surgical Centers
7.3.1.3. Others
7.4. Latin America Atherectomy Devices Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Brazil Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
7.4.1.2. Brazil Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
7.4.1.3. Brazil Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
7.4.1.4. Mexico Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
7.4.1.5. Mexico Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
7.4.1.6. Mexico Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
7.4.1.7. Argentina Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
7.4.1.8. Argentina Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
7.4.1.9. Argentina Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
7.4.1.10. Rest of Latin America Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
7.4.1.11. Rest of Latin America Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
7.4.1.12. Rest of Latin America Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Atherectomy Devices Market Outlook, 2019-2032
8.1. Middle East & Africa Atherectomy Devices Market Outlook, by Type, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Directional Atherectomy
8.1.1.2. Rotational Atherectomy
8.1.1.3. Orbital Atherectomy
8.1.1.4. Laser Atherectomy
8.2. Middle East & Africa Atherectomy Devices Market Outlook, by Indication, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Coronary Artery Diseases
8.2.1.2. Peripheral Artery Diseases
8.3. Middle East & Africa Atherectomy Devices Market Outlook, by End User, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Hospital
8.3.1.2. Ambulatory surgical Centers
8.3.1.3. Others
8.4. Middle East & Africa Atherectomy Devices Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. GCC Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
8.4.1.2. GCC Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
8.4.1.3. GCC Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
8.4.1.4. South Africa Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
8.4.1.5. South Africa Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
8.4.1.6. South Africa Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
8.4.1.7. Egypt Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
8.4.1.8. Egypt Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
8.4.1.9. Egypt Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
8.4.1.10. Nigeria Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
8.4.1.11. Nigeria Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
8.4.1.12. Nigeria Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
8.4.1.13. Rest of Middle East & Africa Atherectomy Devices Market by Type, Value (US$ Bn), 2019-2032
8.4.1.14. Rest of Middle East & Africa Atherectomy Devices Market by Indication, Value (US$ Bn), 2019-2032
8.4.1.15. Rest of Middle East & Africa Atherectomy Devices Market End User, Value (US$ Bn), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Type vs End User Heatmap
9.2. Manufacturer vs End User Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Medtronic Plc
9.5.1.1. Company Overview
9.5.1.2. Type Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Koninkliijke Philips N.V
9.5.2.1. Company Overview
9.5.2.2. Type Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Boston Scientific Corporation
9.5.3.1. Company Overview
9.5.3.2. Type Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Cardiovascular Systems Inc.
9.5.4.1. Company Overview
9.5.4.2. Type Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Avinger Inc.
9.5.5.1. Company Overview
9.5.5.2. Type Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Invamed medical
9.5.6.1. Company Overview
9.5.6.2. Type Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. AngioDynamics Inc.
9.5.7.1. Company Overview
9.5.7.2. Type Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Rex medical
9.5.8.1. Company Overview
9.5.8.2. Type Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Nipro Corporation
9.5.9.1. Company Overview
9.5.9.2. Type Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Becton, Dickinson and Company
9.5.10.1. Company Overview
9.5.10.2. Type Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Medtronic Plc.
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Avinger, Inc.
  • Koninklijke Philips N.V. (Spectranetics + Volcano)